Liposome Formulations of Hydrophobic Drugs
Author:
Publisher
Humana Press
Link
http://link.springer.com/content/pdf/10.1007/978-1-60327-360-2_8.pdf
Reference41 articles.
1. Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A (2005) Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 16:691–707
2. Perez-Lopez ME, Curiel T, Gomez JG, Jorge M (2007) Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer. Anticancer Drugs 18:611–617
3. Porter CA, Rifkin RM (2007) Clinical benefits and economic analysis of pegylated liposomal doxorubicin/vincristine/dexamethasone versus doxorubicin/vincristine/dexamethasone in patients with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma S4:S150–S155
4. Thomas DA, Sarris AH, Cortes J, Faderl S, O’Brien S, Giles FJ, Garcia-Manero G, Rodriguez MA, Cabanillas F, Kantarjian H (2006) Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia. Cancer 106:120–127
5. Hennenfent KL, Govindan R (2006) Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol 17:735–749
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted intracellular delivery of antitubercular bioactive(s) to Mtb infected macrophages via transferrin functionalized nanoliposomes;International Journal of Pharmaceutics;2023-07
2. Liposome bilayer stability: emphasis on cholesterol and its alternatives;Journal of Liposome Research;2023-06-28
3. Development of a concentration‐controlled sequential nanoprecipitation for making lipid nanoparticles with high drug loading;Aggregate;2023-06-17
4. Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms;Anti-Cancer Agents in Medicinal Chemistry;2023-05
5. Skin drug delivery using lipid vesicles: A starting guideline for their development;Journal of Controlled Release;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3